Tempest Therapeutics, Inc. (TPST) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 11.91M |
| Enterprise Value | 12.34M |
| P/E Ratio | -0.2 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 16.62 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.27 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -4.01 |
| Return On Equity | -7.3 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -25.79M |
| Net Income | -26.26M |
| Diluted EPS | -6.33 |
| Total Cash | 1.81M |
| Total Cash/Share | 0.17 |
| Total Debt | 7.85M |
| Total Debt/Equity | 9.55 |
| Current Ratio | 0.74 |
| Book Value Per Share | 0.08 |
| 52-Week Change | -81.75 |
| 52-Week High | 12.23 |
| 52-Week Low | 1.22 |
| Moving Average 50 Days | 1.73 |
| Moving Average 200 Days | 4.48 |
| Average Volume | 207,233 |
| Shares Outstanding | 4.44M |
| % Held by Institutions | 12.46 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:13 |
| Last Split Date | April 09, 2025 |